Growth Metrics

Adaptive Biotechnologies (ADPT) Income from Non-Controlling Interests (2021 - 2025)

Adaptive Biotechnologies (ADPT) has disclosed Income from Non-Controlling Interests for 5 consecutive years, with -$1000.0 as the latest value for Q3 2025.

  • Quarterly Income from Non-Controlling Interests rose 96.15% to -$1000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $42000.0 through Dec 2025, up 140.78% year-over-year, with the annual reading at $42000.0 for FY2025, 140.78% up from the prior year.
  • Income from Non-Controlling Interests hit -$1000.0 in Q3 2025 for Adaptive Biotechnologies, down from $21000.0 in the prior quarter.
  • In the past five years, Income from Non-Controlling Interests ranged from a high of $76000.0 in Q4 2021 to a low of -$95000.0 in Q3 2021.
  • Historically, Income from Non-Controlling Interests has averaged -$18294.1 across 5 years, with a median of -$26000.0 in 2023.
  • Biggest five-year swings in Income from Non-Controlling Interests: plummeted 2500.0% in 2024 and later soared 184.62% in 2025.
  • Year by year, Income from Non-Controlling Interests stood at $76000.0 in 2021, then crashed by 153.95% to -$41000.0 in 2022, then soared by 36.59% to -$26000.0 in 2023, then increased by 3.85% to -$25000.0 in 2024, then skyrocketed by 96.0% to -$1000.0 in 2025.
  • Business Quant data shows Income from Non-Controlling Interests for ADPT at -$1000.0 in Q3 2025, $21000.0 in Q2 2025, and $22000.0 in Q1 2025.